Canary Ambient™ enables actionable insights into patient-clinician dialogues, tracking speech patterns, and delivering real-time evaluations of cognitive and behavioral health conditions
PROVO, Utah, Oct. 16, 2024 /PRNewswire/ — Canary Speech, a leader in vocal biomarker technology, has announced today the launch of Canary Ambient™, an API-first solution designed for healthcare and contact centers, which offers a first-of-its-kind, real-time voice analysis during clinical conversations. Canary Ambient™ is a clinical decision support software enabling actionable insights into patient-clinician dialogues, tracking speech patterns, and real-time assessments of cognitive and behavioral health conditions.
With its advanced voice processing capabilities, Canary Ambient™ brings unobtrusive and impactful insights, helping organizations identify potential at-risk individuals who would benefit from further evaluation, improving overall communication and efficiency of patient care – all done while listening in the background.
“Canary Speech’s clinical ambient listening allows for seamless vocal biomarker analysis that captures the natural interaction between a clinician and their patient with no additional prompting required,” said Nate Blaylock, CTO of Canary Speech. “This technology supports the clinician in identifying patients who may benefit from additional screening.”
“We are thrilled to offer Canary Ambient, which will allow many more organizations to integrate vocal biomarker analysis into existing workflows, improving patient care and customer service,” said Henry O’Connell, CEO of Canary Speech.
Key Features of Canary Ambient™ include:
Canary Ambient™ is now available for healthcare organizations and contact centers looking to enhance their capabilities through voice-driven insights and improve the data-driven support and efficiency provided to clinicians in determining whether further assessment is necessary. For more information on Canary Ambient™, visit this page.
About Canary Speech
Canary Speech is the leading AI-powered voice biomarker health tech company that uses real-time patented vocal analysis to screen for mental health and neurological disorders. Canary’s vocal biomarker technology captures and analyzes speech data within seconds to identify irregularities in behavioral and cognitive changes before current clinical screening standards or noticeable symptoms for invisible illnesses like anxiety, depression and dementia. Canary Speech is a Utah-based company that advances speech and language applications for health systems, payers and pharmaceutical markets.
Press Contact:
Caitlyn Brooksby
caitlyn@canaryspeech.com
Disclaimer: This press release contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those anticipated due to various factors.
SOURCE Canary Speech
To help improve clinician workflow and visualization during endoscopic bronchoscopy procedures, the company has added…
eClinicalWorks and the AI medical scribe assist the 126-provider health center in completing documentation at…
INDIANAPOLIS, Nov. 22, 2024 /PRNewswire/ -- Health centers across the state of Indiana have joined…
SHENZHEN, China, Nov. 22, 2024 /PRNewswire/ -- The 19th Annual Meeting of the International Conference…
CAMBRIDGE, Mass., Nov. 22, 2024 /PRNewswire/ -- SurgiBox, a pioneer in ultra-portable, inflatable surgical environments…
FORT WORTH, Texas, Nov. 22, 2024 /PRNewswire/ -- ESHA, Inc ("ESHA") provide certain revenue cycle…